云南高校图书馆联盟文献共享服务平台- DECITABINE

DECITABINE: 作品数：42被引量：73H指数：5; 导出分析报告; 相关领域：医药卫生更多>>; 相关作者：王琳许小平曹蕾张浩朱尔佳更多>>; 相关机构：台湾神隆股份有限公司复旦大学广东药学院连云港杰瑞药业有限公司更多>>; 相关期刊：《Cellular & Molecular Immunology》《当代医学》《药学进展》《健康大视野》更多>>; 相关基金：国家自然科学基金国家重点基础研究发展计划更多>>

-

在结果中检索

检索结果分析

结果分析中...

选择条件：

期刊=Oncology and Translational Medicine

共条记录，以下是1-2

全选清除导出

参考文献引证文献引用追踪

视图：

排序：

Efficacy and safety of combined decitabine and ruxolitinib in the treatment of chronic myelomonocytic leukemia: 《Oncology and Translational Medicine》2019年第5期237-241,共5页Jiaming Li Sujiang Zhang Yubao Chen Zeying Yan Ying Wang Zhiyin Liu Haimin Sun Yu Chen; Supported by a grant from the Fund of Ruijin Hospital North affiliated to Shanghai Jiao Tong University School of Medicine(No:2018ZY03); Objective The aim of the study was to evaluate the clinical efficacy of decitabine(DEC)combined with ruxolitinib(RUX)in the treatment of chronic myelomonocytic leukemia(CMML).Methods The clinical characteristics of 12...; 关键词：decitabine(DEC) ruxolitinib(RUX) CHRONIC myelomonocytic leukemia(CMML)

Gene mutations in a patient with chronic myelomonocytic leukemia and changes upon progression to acute myeloid leukemia and during treatment被引量：2: 《Oncology and Translational Medicine》2019年第1期30-32,共3页Jiaming Li Sujiang Zhang; Supported by a grant from the Foundation of Ruijin Hospital North Affiliated with Shanghai Jiao Tong University School of Medicine(No.2018ZY03); Objective Chronic myelomonocytic leukemia(CMML) has been categorized as an uncommon hematological malignancy with overlapping features of myelodysplastic syndromes(MDS) and myeloproliferative neoplasms that have an in...; 关键词：chronic myelomonocytic LEUKEMIA acute MYELOID LEUKEMIA mutation DECITABINE BORTEZOMIB PLATELETS SETD2 LILRB4

全选清除导出

共1页<1>

检索报告对象比较聚类工具使用帮助返回顶部